Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-02-17

Clinical Trial Update: Megestrol Acetate for the Improvement of Quality of Life in Esophageal Cancer With Chemoradiotherapy [Phase 3]

View source ↗

Summary

Phase 3 clinical trial investigating megestrol acetate to improve quality of life in patients with esophageal squamous cell carcinoma undergoing chemoradiothera…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Megestrol acetate (megestrol acetate)

Snippet

Sponsor: The First Affiliated Hospital of Henan University of Science and Technology | Conditions: Stage III Esophageal Squamous Cell Carcinoma, Stage II Esophageal Squamous Cell Carcinoma | Phase 3 | Status: COMPLETED